Skip to content

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

Christopher L German, Annette E Fleckenstein, Glen R. Hanson

Life Sciences February 27, 2014 DOI: 10.1016/j.lfs.2013.07.023 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Keywords Bath salts Designer drugs Mdpv Mephedrone Methylone Stimulants Synthetic cathinone
Key findings The review indicates that synthetic cathinones, abused for effects similar to cocaine, MDMA, and amphetamines, act mainly by dysregulating central monoamine systems, which presumably underlies their behavioral effects and abuse liability. It also outlines their emergence as 'bath salts' products, their legal classification in Europe and the US, and discusses the benefits and drawbacks of that classification.

Abstract

Synthetic cathinones are an emerging class of designer drugs abused for psychostimulant and hallucinogenic effects similar to cocaine, methylenedioxymethamphetamine (MDMA), or other amphetamines. Abuse of synthetic cathinones, frequently included in products sold as 'bath salts', became prevalent in early 2009, leading to legislative classification throughout Europe in 2010 and schedule I classification within the United States in 2011. Recent pre-clinical and clinical studies indicate that dysregulation of central monoamine systems is a principal mechanism of synthetic cathinone action and presumably underlie the behavioral effects and abuse liability associated with these drugs. This review provides insight into the development of synthetic cathinones as substances of abuse, current patterns of their abuse, known mechanisms of their action and toxicology, and the benefits and drawbacks of their classification.

Citations in the library

Cited by 17

and 12 more in the library

Cites 8

and 3 more in the library

Explore topics